Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Share-based Payment Award, Valuation Assumptions

The following table includes the weighted-average assumptions used in estimating the fair values and the resulting weighted-average fair value of stock options granted in the periods presented:

	Year Ended December 31,
	2022			2021			2020
Weighted average fair values of stock options granted	$	—		$	15.53		$	15.58
Expected volatility	—		%	77.1		%	64.7		%
Expected dividends	—		%	.99		%	.84		%
Weighted average risk-free interest rate	—		%	.93		%	.24		%
Expected life of stock options (in years)	0.00			3.5			3.5

Schedule of Stock Options Activity

A summary of stock option activity for the years ended December 31, 2022, 2021, and 2020 is as follows:

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
					(In thousands)
Outstanding at January 1, 2020	217,875	$	43.78	2.6	$	—
Granted	36,000	$	35.70
Exercised	(30,000)	$	21.19
Canceled	(6,000)	$	28.59
Outstanding at December 31, 2020	217,875	$	45.97	2.6	$	—
Granted	42,000	$	30.40
Exercised	—	$	—
Canceled	(40,875)	$	49.22
Outstanding at December 31, 2021	219,000	$	42.38	2.8	$	—
Granted	—	—
Exercised	—	—
Canceled	(39,000)	$	49.22
Outstanding at December 31, 2022	180,000	$	39.89	2.3	$	—
Exercisable at December 31, 2022	120,000	$	42.50	1.8	$	—

Schedule of Nonvested Share Activity

A summary of non-vested options and changes for the years ended December 31, 2022, 2021 and 2020 is as follows:

	Non-Vested Number of Shares	Weighted Average Exercise Price
Non-vested balance at January 1, 2020	108,750	$	46.65
Granted	36,000	$	35.70
Vested	(42,000)	$	47.66
Canceled	—	$	—
Non-vested balance at December 31, 2020	102,750	$	42.40
Granted	42,000	$	30.40
Vested	(39,750)	$	44.24
Canceled	—	$	—
Non-vested balance at December 31, 2021	105,000	$	36.90
Granted	—	$	—
Vested	(45,000)	$	39.89
Canceled	—	$	—
Non-vested balance at December 31, 2022	60,000	$	34.66

Schedule of Shares Authorized under Stock Option Plans, by Exercise Price Range

The following table summarizes information about stock options outstanding by price range as of December 31, 2022:

	Options Outstanding					Options Exercisable
Exercise Prices	Number Outstanding	Weighted-Average Remaining Contractual Life (Years)	Weighted-Average Exercise Price			Number of Shares	Weighted-Average Exercise Price
$30.40	42,000	0.91	$	7.09	2	10,500	$	2.66
$35.70	36,000	0.59	$	7.14		18,000	$	5.36
$41.60	36,000	0.35	$	8.32		29,250	$	10.14
$42.56	36,000	0.20	$	8.51		36,000	$	12.77
$52.92	30,000	0.24	$	8.82		26,250	$	11.58
	180,000	0	$	39.87		120,000	$	42.51

Schedule of Nonvested Restricted Stock Activity

A summary of the status of the Company’s non-vested restricted stock grant shares is presented in the following table:

	Shares	Weighted-Average Grant Date Fair Value
Non-vested at January 1, 2020	107,954	$	52.08
Granted	388,089	$	24.37
Vested	(68,504)	$	52.49
Forfeited	—	$	—
Non-vested at December 31, 2020	427,539	$	26.86
Granted	8,979	$	27.84
Vested	(213,993)	$	29.08
Forfeited	—	$	—
Non-vested at December 31, 2021	222,525	$	24.76
Granted	2,871	$	29.61
Vested	(141,206)	$	25.88
Forfeited	—	$	—
Non-vested at December 31, 2022	84,190	$	23.05